Last month, we reported on a troubling incident at the annual meeting of the American Diabetes Association (ADA) in New ...
Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Turmoil at the American ...
The hidden cost GLP boom shows total payments rose sharply from 2017-2022 despite lower out-of-pocket costs, impacting insurers and Medicare programs.
Legal professionals from across the nation will convene July 29-Aug. 4 in Chicago for the American Bar Association 2026 Annual Conference, where attorneys, judges and legal scholars will examine press ...
The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...
A look back at the speakers and educational programs at ALA's 2026 Annual Conference and Exhibition in Chicago.
An insulin inhaler proved safe for treating children as young as 4 years old, improving satisfaction and reducing weight gain ...
Should all adults with diabetes, including those who are asymptomatic, be screened for peripheral vascular disease (PAD)? According to Shihchen Kuo, RPh, PhD, associate research scientist of internal ...
Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians ...
How the American Diabetes Association tried to hide a critical editorial published in its own journal—to no avail.
Dairy and the Environment: Challenges and Opportunities brings nutritionists, geneticists, and agronomists together to work through what’s actually moving the needle on-farm this August. For the ...
GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results